Ju Kon Kim
Corporate Officer/Principal bij Myongji University
Profiel
Ju Kon Kim is currently the Head of the Biology Department at Myongji University, a position he has held since 1995.
Prior to this, he worked as a Research Scientist at Seoul National University from 1979 to 1995.
He also served as the Chief Scientific Officer at GreenGene BioTech, Inc. Additionally, he earned a doctorate degree from Cornell University in 1990, an undergraduate degree from Seoul National University in 1977, and a graduate degree from Korea Advanced Institute of Science & Technology in 1979.
Actieve functies van Ju Kon Kim
| Bedrijven | Functie | Begin |
|---|---|---|
| Myongji University | Corporate Officer/Principal | 29-04-2011 |
Eerdere bekende functies van Ju Kon Kim
| Bedrijven | Functie | Einde |
|---|---|---|
| Seoul National University | Chief Tech/Sci/R&D Officer | 01-01-1995 |
GreenGene BioTech, Inc.
 GreenGene BioTech, Inc. BiotechnologyHealth Technology GreenGene BioTech, Inc. is a holding company, which engages in rice plant gene development and commercialization. Its products include protein binding and expression microarray. It also provides primer walking, flanking deoxyribonucleic acid, and whole genome services. The company was founded in March 2000 and is headquartered in Yongin-si, South Korea. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Ju Kon Kim
| Cornell University | Doctorate Degree |
| Seoul National University | Undergraduate Degree |
| Korea Advanced Institute of Science & Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
GreenGene BioTech, Inc.
GreenGene BioTech, Inc. BiotechnologyHealth Technology GreenGene BioTech, Inc. is a holding company, which engages in rice plant gene development and commercialization. Its products include protein binding and expression microarray. It also provides primer walking, flanking deoxyribonucleic acid, and whole genome services. The company was founded in March 2000 and is headquartered in Yongin-si, South Korea. | Health Technology |
